Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Comprehensive Loss (Unaudited)

v3.20.2
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Statement of Comprehensive Income [Abstract]        
Revenue $ 1 $ 4 $ 29 $ 5
Cost of revenue 10 2 40 3
Gross profit (loss) (9) 2 (11) 2
Operating expenses:        
Research and development 1,264 2,129 3,199 4,533
Sales and marketing 582 1,156 2,445 2,313
General and administrative 2,365 2,364 5,277 5,161
Total operating expenses 4,211 5,649 10,921 12,007
Operating loss (4,220) (5,647) (10,932) (12,005)
Gain (loss) on change in estimated fair value of contingent royalty obligation (76) (86) 245 (59)
Finance income (expense), net (119) 59 (231) 119
Foreign currency gain (loss) 5 (7) (3) (9)
Loss before income taxes (4,410) (5,681) (10,921) (11,954)
Income tax expense
Net loss $ (4,410) $ (5,681) $ (10,921) $ (11,954)
Basic and diluted loss per common share $ (0.15) $ (0.26) $ (0.38) $ (0.56)
Weighted average number of common shares outstanding, basic and diluted 28,846,881 21,450,877 28,832,296 21,447,218